Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00892515 · ClinicalTrials.gov registry record · NA
Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer
A NA study of Breast Cancer and Healthy, no Evidence of Disease, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 183
- Enrollment target
- 1
- Study location
NCT00892515: Completed NA study of Breast Cancer and Healthy, no Evidence of Disease, sponsored by Abramson Cancer Center at Penn Medicine.
NCT00892515 is a NA study of Breast Cancer and Healthy, no Evidence of Disease that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 183 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00892515, a NA study of Breast Cancer and Healthy, no Evidence of Disease, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 183 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Exercise may change the risk of developing breast cancer. It is not yet known whether low-intensity exercise or high-intensity exercise is more effective in lowering the risk of breast cancer. PURPOSE: This randomized clinical trial is studying how well exercise programs work in healthy young women at increased risk of developing breast cancer.
Conditions Studied
Interventions
- BEHAVIORAL exercise intervention
- OTHER counseling intervention
- OTHER immunoenzyme technique
- OTHER immunologic technique
- OTHER gas chromatography
Study Locations (1)
Pennsylvania
- Abramson Cancer Center of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2008-10 |
| Est. Completion | 2016-05-20 |
| Phase | NA |
What the finished NCT00892515 record still lists
NCT00892515 is an interventional study that assigns participants to a tested intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which exercise intervention is the first listed.
NCT00892515 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00892515 about?
NCT00892515 is a clinical study titled "Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer". RATIONALE: Exercise may change the risk of developing breast cancer. It is not yet known whether low-intensity exercise or high-intensity exercise is more effective in lowering the risk of breast cancer. PURPOSE: This randomized clinical trial is studying how well exercise programs work in healthy ...
What is the current status of trial NCT00892515?
This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2008-10. Estimated completion is 2016-05-20.
What conditions does trial NCT00892515 study?
This clinical trial studies the following conditions: Breast Cancer, Healthy, no Evidence of Disease.
What interventions are being tested in trial NCT00892515?
The interventions under investigation include: exercise intervention (BEHAVIORAL), counseling intervention (OTHER), immunoenzyme technique (OTHER), immunologic technique (OTHER), gas chromatography (OTHER).
Who is sponsoring clinical trial NCT00892515?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00892515 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00892515's enrollment target sits among peer trials
183 402nd of 1224 higher than 821 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia